Don’t miss the latest developments in business and finance.

Strides Shasun receives approval for Amantadine Hydrochloride Tablets

Image
Capital Market
Last Updated : Jun 13 2017 | 12:01 AM IST

From USFDA

Strides Shasun has received approval from USFDA for Amantadine Hydrochloride Tablets 100 mg. The product received approval in 15 months under the new GDUFA regime. The product will be launched immediately.

The Company also recently received USFDA approval for Amantadine Hydrochloride Capsules and the combined market size of Tablets and Capsules is approximately USD 47 million.

Powered by Capital Market - Live News

Also Read

First Published: Jun 12 2017 | 9:25 AM IST

Next Story